The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Knop
Filip K
FK
Vilsbøll
Tina
T
Lund
Asger
A
Krarup
Thure
T
Holst
Jens J
JJ
Hornum
Mads
M
D056947:Enzyme Replacement Therapy / Q000379:methods; D010188:Exocrine Pancreatic Insufficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1 / Q000097:blood / Q000378:metabolism; D053767:Glucagon-Like Peptide 2 / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D010179:Pancreas / Q000201:enzymology; D050500:Pancreatitis, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D020799:Pancrelipase / Q000627:therapeutic use*; D019518:Postprandial Period / Q000187:drug effects
D005765:Gastrointestinal Agents; D053767:Glucagon-Like Peptide 2; D020799:Pancrelipase; D052216:Glucagon-Like Peptide 1